{"id": "265092", "url": "https://fevir.net/resources/Group/265092", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/conceptual-cohort-definition"], "versionId": "5", "lastUpdated": "2025-03-15T21:02:00.141Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\">[No data.]</div>", "status": "empty"}, "title": "Diabetes treatment medication", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Sheyu Li"}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "Diabetes treatment medication [Database Entry: FHIR Group Resource]. Contributors: Sheyu Li [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 265092. Revised 2024-11-16. Available at: https://fevir.net/resources/Group/265092. Computable resource at: https://fevir.net/resources/Group/265092#json."}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "265092", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "membership": "conceptual", "description": "SGLT-2 inhibitors, GLP-1 receptr agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, thiazolidinediones, sulfonylureas, metformin, \u03b1-glucosidase inhibitors, meglitinides, insulins, dual GIP/GLP-1 receptor agonists, or non-steroidal mineralocorticoid receptor antagonists", "resourceType": "Group", "characteristic": [{"code": {"text": "Drug class"}, "exclude": false, "description": "SGLT-2 inhibitors", "valueCodeableConcept": {"text": "SGLT-2 inhibitor"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "GLP-1 receptr agonists", "valueCodeableConcept": {"text": "GLP-1 receptr agonist"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "DPP-4 inhibitors", "valueCodeableConcept": {"text": "DPP-4 inhibitor"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "thiazolidinediones", "valueCodeableConcept": {"text": "thiazolidinedione"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "sulfonylureas", "valueCodeableConcept": {"text": "sulfonylurea"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "metformin", "valueCodeableConcept": {"text": "metformin"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "\u03b1-glucosidase inhibitors", "valueCodeableConcept": {"text": "\u03b1-glucosidase inhibitor"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "meglitinides", "valueCodeableConcept": {"text": "meglitinide"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "insulins", "valueCodeableConcept": {"text": "insulin"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "dual GIP/GLP-1 receptor agonists", "valueCodeableConcept": {"text": "dual GIP/GLP-1 receptor agonist"}}, {"code": {"text": "Drug class"}, "exclude": false, "description": "non-steroidal mineralocorticoid receptor antagonists", "valueCodeableConcept": {"text": "non-steroidal mineralocorticoid receptor antagonist"}}], "combinationMethod": "any-of"}